The 26-foot-tall (8-meter-tall) cargo lander is expected to embark on its first flight during the first quarter of 2026, ...

Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...

Introduction The global evidence base on intimate partner violence (IPV) prevalence and risk factors is predominantly cross-sectional, limiting clarity in changes over time. Prospective cohort data ...

The system employs HMAC-SHA256 (Hash-based Message Authentication Code using SHA-256) for license integrity verification. SHA-256 refers to the Secure Hash Algorithm producing 256-bit hash values (see ...

How a study of the Bible in different languages or versions can augment an understanding of the Savior’s gospel ...

Ford is recalling more than 270,000 electric and hybrid vehicles in the U.S. because of a parking function problem that could lead to them rolling away.

Share on Pinterest According to research, most people may not be getting enough omega-3 fatty acids in their diet. Image Credit: Tanja Ivanova/Getty Images A new research review reports that most ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...

- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria in primary membranous nephropathy, and stabilization of estimated ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. C3 glomerulopathy is an ultra-rare, severe form of glomerulonephritis caused by overactivation of the ...

An analysis of data from the Colorado Longitudinal Twin Study suggests that general cognitive ability tends to be highly stable across the lifespan, but this stability only emerges after about age 3.

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...